We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Allows Use of New Blue Color Additive for Drug Tablet, Capsule Coatings
FDA Allows Use of New Blue Color Additive for Drug Tablet, Capsule Coatings
The FDA is amending its color additive regulations to allow for the use of spirulina extract in coating formulations for drug tablets and capsules — giving drugmakers an alternative blue color that is exempt from safety certification requirements.